Nanjing Medical Company Limited announced that the Company will sell the 30% stake in a Nanjing-based pharmaceutical company to Cal-Nan Horizon Quest Inc at RMB 30 million and the 46% stake in another Nanjing-based company (Company A) to the Company's control subsidiary (Company B). The Company has also authorized Company B to purchase the 20% stake in Company A from a Nanjing-based pharmaceutical corporate group at RMB 11,437,480.